Back
Zai Lab Vs. NovoCure Industry Stock Comparison
Sell
45
ZLAB
Zai Lab
Last Price:
$30.13
Seasonality Move:
9.19%
Sell
33
NVCR
NovoCure
Last Price:
$19.12
Seasonality Move:
3.27%
Sell
45
Zai Lab (ZLAB)
is a Sell
Is Zai Lab a Buy, Sell or Hold?
-
ZLAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZLAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 46.27 | Sell |
Chaikin Money Flow: | -335370 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.27 - 32.17) | Sell |
Bollinger Bands (100): | (26.82 - 34.66) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 58.47 | Buy |
Chaikin Money Flow: | 625970 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.32 - 18.82) | Buy |
Bollinger Bands (100): | (16.76 - 24.36) | Sell |
ZLAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.47 | Sell |
20-day SMA: | 30.44 | Sell |
50-day SMA: | 31.67 | Sell |
200-day SMA: | 27.72 | Buy |
8-day EMA: | 30.94 | Sell |
20-day EMA: | 30.91 | Sell |
50-day EMA: | 31.16 | Sell |
200-day EMA: | 28.45 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.71 | Buy |
20-day SMA: | 18.03 | Buy |
50-day SMA: | 17.72 | Buy |
200-day SMA: | 20.23 | Sell |
8-day EMA: | 18.81 | Buy |
20-day EMA: | 18.29 | Buy |
50-day EMA: | 18.48 | Buy |
200-day EMA: | 20.2 | Sell |
Zai Lab Earnings Growth & ZLAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.43 per share, an increase this year of $1.26 per share, and an increase next year of $1.53 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.
Zai Lab Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |